Smurfit Kappa Group CapEx increased by 7.0% to $624.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 30.8%, from $477.00M to $624.00M. Over 2 years (FY 2022 to FY 2025), CapEx shows an upward trend with a 53.5% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $232.50M | $232.50M | $232.50M | $232.50M | $268.00M | $208.00M | $177.00M | $512.00M | $569.00M | $477.00M | $522.00M | $610.00M | $583.00M | $624.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +15.3% | -22.4% | -14.9% | +189.3% | +11.1% | -16.2% | +9.4% | +16.9% | -4.4% | +7.0% |
| YoY Change | — | — | — | — | +15.3% | — | — | — | +112.3% | +129.3% | +194.9% | +19.1% | +2.5% | +30.8% |